Advertisement

Topics

Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28

08:19 EDT 9 Aug 2017 | Xconomy

Dragonfly Therapeutics is one of the more unusual biotech startups to come along of late. It was formed by well-known cancer researchers on both coasts, backed by some high-powered family offices, and already has a partnership with Celgene—all without the presence or help of a single venture firm. Two of Dragonfly’s co-founders, cancer research pioneer […]

Original Article: Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28

NEXT ARTICLE

More From BioPortfolio on "Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...